<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03478254</url>
  </required_header>
  <id_info>
    <org_study_id>C-127</org_study_id>
    <nct_id>NCT03478254</nct_id>
  </id_info>
  <brief_title>Adherence to Guidelines VAccination in Type 1 DIabetes Mellitus Patients (AVADI-1).</brief_title>
  <acronym>AVADI-1</acronym>
  <official_title>Adherence to Guidelines for Influenza, Pneumococcal and Hepatitis B Vaccination in Adult Patients With Type 1 Diabetes Mellitus (AVADI-1).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jesús Moreno Fernández</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Castilla-La Mancha Health Service</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Castilla-La Mancha</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Castilla-La Mancha Health Service</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational study about adherence to guidelines for Influenza, Pneumococcal and Hepatitis B
      Vaccination in adult patients with type 1 Diabetes mellitus.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cross-sectional analysis about adherence to guidelines for Influenza, Pneumococcal and
      Hepatitis B Vaccination in adult patients with type 1 Diabetes mellitus.

      All clinical variables are gathered from two EMR softwares (Mambrino XXI and Turriano).

      Data analysis is conducted using SPSS (Chicago, IL) statistics software. Results are
      presented as mean ± SD values or percentages. A paired Student's t-test or a Wilcoxon
      signed-rank test were used for the analysis of differences. Comparisons between proportions
      were analyzed using a chi-squared test. A P value &lt; 0.05 was considered statistically
      significant.

      The protocol was approved by the reference Castilla-La Mancha Public Health Institute Ethic
      Committee. All participants provided written informed consent.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Adherence to regional guidelines for the immunization of adults with type 1 diabetes mellitus (T1DM</measure>
    <time_frame>1 year</time_frame>
    <description>Adherence to Influenza, Pneumococcal and Hepatitis B Vaccination in adult patients with type 1 Diabetes mellitus.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Predictors of vaccination</measure>
    <time_frame>1 year</time_frame>
    <description>Any situation indentified as inducing greater vaccination rate.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relationship between adherence vaccination and related sick leaves</measure>
    <time_frame>1 year</time_frame>
    <description>Number and duration of related sick leaves.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Type 1 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Influenza Vaccination</arm_group_label>
    <description>All type 1 diabetes adults patients attended in Ciudad Real General University Hospital willl be checked for Influenza Vaccination status.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pneumococcal Vaccination</arm_group_label>
    <description>All type 1 diabetes adults patients attended in Ciudad Real General University Hospital willl be checked for Pneumococcal Vaccination status.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hepatitis B Virus (HBV) Vaccination</arm_group_label>
    <description>All type 1 diabetes adults patients attended in Ciudad Real General University Hospital willl be checked for Hepatitis B Virus (HBV) status.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Influenza vaccination</intervention_name>
    <description>Correct influenza vaccination status was considered in the following situation:
- Received at least one Influenza vaccine dose in the last year.</description>
    <arm_group_label>Influenza Vaccination</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Pneumococcal vaccination</intervention_name>
    <description>Correct pneumococal vaccination status was considered if a subject received at least one of the following options:
One pneumococcal conjugate vaccine (PCV) 13 dose in the last year.
One PCV13 dose following a pneumococcal polysaccharide vaccine (PPSV) 23 dose between the following 8 weeks and 12 months.
One PPSV 23 dose in the last 5 years.
One PPSV23 dose in the last 5 years and a second PPSV23 dose at 5 years or PCV13 at 1 year.</description>
    <arm_group_label>Pneumococcal Vaccination</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Hepatitis B Virus (HBV) vaccination</intervention_name>
    <description>Correct Hepatitis B Virus (HBV) vaccination status was considered in the following situation:
.- Received at least three consecutive doses of HBV vaccine during six consecutive months.</description>
    <arm_group_label>Hepatitis B Virus (HBV) Vaccination</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients attended to care in consults during this period were eligible for chart
        review. Patients included in the analysis were required to be ≥18 years of age and be
        diagnosed of type 1 diabetes mellitus.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ≥18 years of age.

          -  Diagnosed of Type 1 Diabetes Mellitus.

          -  Be attended in Ciudad Real General University Hospital.

        Exclusion Criteria:

          -  Less than 18 years old.

          -  Other types of diabetes mellitus.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elena M Ortega Rodrigo</last_name>
    <role>Study Chair</role>
    <affiliation>University of Castilla-La Mancha</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jose Alberto Garcia Seco, RN</last_name>
    <role>Study Chair</role>
    <affiliation>University of Castilla-La Mancha</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fernando Garcia Seco</last_name>
    <role>Study Chair</role>
    <affiliation>Universidad de Córdoba</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Angela M Seco Segura, RN</last_name>
    <role>Study Chair</role>
    <affiliation>Castilla-La Mancha Health Service</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jesus Moreno-Fernandez, PhD</last_name>
    <phone>926278000</phone>
    <phone_ext>79509</phone_ext>
    <email>jmorenof@sescam.jccm.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Angela Seco Segura, RN</last_name>
    <phone>926278000</phone>
    <phone_ext>79510</phone_ext>
    <email>amsese@live.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Obispo Rafael Torija, St.</name>
      <address>
        <city>Ciudad Real</city>
        <zip>13005</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jesus Moreno-Fernandez, MD, PhD</last_name>
      <phone>926278000</phone>
      <phone_ext>79509</phone_ext>
      <email>jmorenof@sescam.jccm.es</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care. 2003 Feb;26(2):510-3.</citation>
    <PMID>12547890</PMID>
  </reference>
  <reference>
    <citation>Muller LM, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, Hoepelman AI, Rutten GE. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis. 2005 Aug 1;41(3):281-8. Epub 2005 Jun 16.</citation>
    <PMID>16007521</PMID>
  </reference>
  <reference>
    <citation>Alcusky MJ, Pawasauskas J. Adherence to Guidelines for Hepatitis B, Pneumococcal, and Influenza Vaccination in Patients With Diabetes. Clin Diabetes. 2015 Jul;33(3):116-22. doi: 10.2337/diaclin.33.3.116.</citation>
    <PMID>26203204</PMID>
  </reference>
  <reference>
    <citation>Sastre J, Pinés PJ, Moreno J, Aguirre M, Blanco B, Calderón D, Herranz S, Roa C, Lopez J; Grupo de estudio DIACAM 1. Metabolic control and treatment patterns in patients with type 1 diabetes in Castilla-La Mancha: the DIAbetes tipo 1 in Castilla La Mancha study. Endocrinol Nutr. 2012 Nov;59(9):539-46. doi: 10.1016/j.endonu.2012.07.003. Epub 2012 Oct 4. English, Spanish.</citation>
    <PMID>23039989</PMID>
  </reference>
  <reference>
    <citation>American Association of Diabetes Educators. Vaccination practices for hepatitis B, influenza, and pneumococcal disease for people with diabetes. Diabetes Educ. 2014 Jan-Feb;40(1):122-4. doi: 10.1177/0145721713513545.</citation>
    <PMID>24442103</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 20, 2018</study_first_submitted>
  <study_first_submitted_qc>March 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2018</study_first_posted>
  <last_update_submitted>March 27, 2018</last_update_submitted>
  <last_update_submitted_qc>March 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Castilla-La Mancha Health Service</investigator_affiliation>
    <investigator_full_name>Jesús Moreno Fernández</investigator_full_name>
    <investigator_title>Endocrinology and Nutrition Service, MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>In request.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

